Angioplasty, Outcomes and Pulmonary - Cardiovascular Update

Chronic Thromboembolic Pulmonary Hypertension: the therapeutic assessment

Frontiers in Cardiovascular Medicine

JULY 24, 2024

Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a severe and complex condition that evolves from unresolved pulmonary embolism, leading to fibrotic obstruction of pulmonary arteries, pulmonary hypertension, and potential right heart failure.

Pulmonary

Pulmonary Hypertension Angioplasty Pharmacology

Continuous heart monitoring to evaluate treatment effects in pulmonary hypertension

Open Heart

MAY 7, 2024

Background The treatment of pulmonary hypertension (PH) has improved rapidly in recent decades. There is increasing evidence to support the role of early intervention and treatment in affecting clinical outcomes in PH. Methods Patients were compared before and after treatment escalation.

Heart Monitor

Heart Monitor Pulmonary Hypertension Angioplasty

Patient-specific 3D in vitro modeling and fluid dynamic analysis of primary pulmonary vein stenosis

Frontiers in Cardiovascular Medicine

JULY 5, 2024

IntroductionPrimary pulmonary vein stenosis (PVS) is a rare congenital heart disease that proves to be a clinical challenge due to the rapidly progressive disease course and high rates of treatment complications. These 3D reconstructions were 3D printed using a clear resin ink and used in a benchtop experimental setup.

Stenosis

Stenosis Pulmonary Congenital Heart Disease Stents

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Top Specialties in Fellowship Programs and What They Offer: An In-depth Look for Medical Professionals

ADN Center of Excellence

NOVEMBER 7, 2024

Our Interventional Cardiology Fellowship Program offers a unique opportunity for fellows to immerse themselves in high-volume centers and experience complex procedures such as angioplasties, stent placements, and Chronic Total Occlusion (CTO) interventions. Requirements This specialty requires a background in internal medicine or pediatrics.

Cancer

Cancer Academic Research Interventional Cardiology

BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes

DAIC

MAY 2, 2024

a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the primary endpoint results of the open label roll-in cohort of the CardiAMP Cell Therapy in Chronic Myocardial Ischemia Trial. Getty Images milla1cf Thu, 05/02/2024 - 10:12 May 2, 2024 — BioCardia, Inc. ,

Ischemia

Ischemia Angina Heart Failure Outcomes

Stent‐in‐Stent Intervention for Pulmonary Vein in Stent Restenosis: A Long‐Term Follow‐Up Case Report

Journal of Cardiovascular Electrophysiology

NOVEMBER 20, 2024

ABSTRACT Introduction Pulmonary vein (PV) restenosis develops with reported incidence rates of up to 50%. Balloon angioplasty seems to be the widely preferred treatment of choice. Conclusion Our case demonstrates stenting as a viable alternative strategy with potentiallyfavorable long-term outcome.

Stents

Stents Stent Pulmonary Angioplasty

A Relatively Narrow Complex Tachycardia at a Rate of 180.

Dr. Smith's ECG Blog

FEBRUARY 8, 2015

There was a good outcome. Second , if the patient is hemodynamically stable, without pulmonary edema, it may be wise to try some fluids and and benzodiazepines and/or propofol for this post-seizure patient with likely high catecholamine levels. This would treat both SVT or sinus tachycardia. Later, he was found to have used cocaine.

Tachycardia

Tachycardia Chest Pain Pharmacology Myocardial Infarction

Abstract 4139207: Supraselective Administration of Very Low-dose Intracoronary Epinephrine as a Rescue and First-line Drug for the Management of No-reflow in Conjunction With the IIB-IIIA Inhibitor Tirofiban.

Circulation

NOVEMBER 11, 2024

to 10% of percutaneous coronary interventions (PCI), no-reflow is a complication associated with poor outcomes like myocardial infarction extension and death. However, one patient with LVEF 20% died of pulmonary edema 7 hours postangioplasty. Circulation, Volume 150, Issue Suppl_1 , Page A4139207-A4139207, November 12, 2024.

Myocardial Infarction

Myocardial Infarction Angioplasty Pulmonary Arrhythmia

How does Acute Total Left Main Coronary occlusion present on the ECG?

Dr. Smith's ECG Blog

AUGUST 9, 2019

Here is another proven left main occlusion in a young woman who presented with sudden pulmonary edema, had this ECG recorded, then arrested and was resuscitated after 30 minutes of CPR: This has sinus tachycardia with RBBB and LAFB, and STE in V2-V6 as well as I, aVL This pattern could just as easily be seen in LAD occlusion.

Myocardial Infarction

Myocardial Infarction Ischemia STEMI Cardiogenic Shock

The First 60 Minutes of a Heart Attack: The Golden Hour

Wellnest

JULY 19, 2023

It is imperative to act swiftly when faced with such a medical emergency to ensure the best possible outcome. Once the patient reaches the hospital, the doctors will attempt to remove the clot using either a potent clot buster medicine [thrombolytic medicines] or a surgery known as primary angioplasty.

Heart Attack

Heart Attack Heart attacks Blood Pressure Myocardial Infarction

Right ventricular remodelling and long-term survival after pulmonary endarterectomy versus balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension

Heart BMJ

JANUARY 13, 2025

Background Pulmonary endarterectomy (PEA) is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), while balloon pulmonary angioplasty (BPA) is an alternative for inoperable patients. The TAPSE/systolic pulmonary artery pressure ratio improved similarly in both groups. 95% CI 0.82

Pulmonary

Pulmonary Angioplasty Hypertension Tricuspid

Surgical outcomes in adolescents and adults with anomalous aortic origin of a coronary artery

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

This study aims to evaluate the medium-term outcomes of surgical repair for AAOCA and to introduce a novel off-pump technique for anomalous coronary artery reimplantation.MethodsWe retrospectively reviewed the medical records of 12 patients aged 12 years and older who underwent AAOCA surgery at Fuwai Hospital between 2009 and 2016.ResultsThe

Aortic

Aortic Sudden Cardiac Death Angioplasty Outcomes

Chronic Thromboembolic Pulmonary Hypertension: the therapeutic assessment

Continuous heart monitoring to evaluate treatment effects in pulmonary hypertension

Patient-specific 3D in vitro modeling and fluid dynamic analysis of primary pulmonary vein stenosis

Webinars

Top Specialties in Fellowship Programs and What They Offer: An In-depth Look for Medical Professionals

BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes

Stent‐in‐Stent Intervention for Pulmonary Vein in Stent Restenosis: A Long‐Term Follow‐Up Case Report

A Relatively Narrow Complex Tachycardia at a Rate of 180.

Abstract 4139207: Supraselective Administration of Very Low-dose Intracoronary Epinephrine as a Rescue and First-line Drug for the Management of No-reflow in Conjunction With the IIB-IIIA Inhibitor Tirofiban.

How does Acute Total Left Main Coronary occlusion present on the ECG?

The First 60 Minutes of a Heart Attack: The Golden Hour

Right ventricular remodelling and long-term survival after pulmonary endarterectomy versus balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension

Surgical outcomes in adolescents and adults with anomalous aortic origin of a coronary artery

Stay Connected